Literature DB >> 32791075

Lipoprotein-based drug delivery.

Sara Busatto1, Sierra A Walker2, Whisper Grayson3, Anthony Pham2, Ming Tian2, Nicole Nesto3, Jacqueline Barklund3, Joy Wolfram4.   

Abstract

Lipoproteins (LPs) are circulating heterogeneous nanoparticles produced by the liver and intestines. LPs play a major role in the transport of dietary and endogenous lipids to target cells through cell membrane receptors or cell surface-bound lipoprotein lipase. The stability, biocompatibility, and selective transport of LPs make them promising delivery vehicles for various therapeutic and imaging agents. This review discusses isolation, manufacturing, and drug loading techniques used for LP-based drug delivery, as well as recent applications for diagnosis and treatment of cancer, atherosclerosis, and other life-threatening diseases.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biocompatible nanoparticles; Chemotherapy; Chylomicrons; Drug delivery; High-density lipoproteins; Low-density lipoproteins; Lymphatic transport; Purification; Synthetic lipoproteins; Very low-density lipoproteins

Year:  2020        PMID： 32791075      PMCID： PMC7747060          DOI： 10.1016/j.addr.2020.08.003

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN： 0169-409X            Impact factor:   15.470


  135 in total

Review 1.  High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

Authors:  Rui Kuai; Dan Li; Y Eugene Chen; James J Moon; Anna Schwendeman
Journal:  ACS Nano       Date:  2016-02-25       Impact factor: 15.881

2.  Enhanced delivery of rapamycin by V156K-apoA-I high-density lipoprotein inhibits cellular proatherogenic effects and senescence and promotes tissue regeneration.

Authors:  Kyung-Hyun Cho
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-09-28       Impact factor: 6.053

3.  Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group.

Authors:  I Ray-Coquard; A Le Cesne; M T Rubio; J Mermet; C Maugard; A Ravaud; C Chevreau; C Sebban; T Bachelot; P Biron; J Y Blay
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

4.  Multi-step encapsulation of chemotherapy and gene silencing agents in functionalized mesoporous silica nanoparticles.

Authors:  Jianliang Shen; Haoran Liu; Chaofeng Mu; Joy Wolfram; Wei Zhang; Han-Cheon Kim; Guixian Zhu; Zhongbo Hu; Liang-Nian Ji; Xuewu Liu; Mauro Ferrari; Zong-Wan Mao; Haifa Shen
Journal:  Nanoscale       Date:  2017-04-20       Impact factor: 7.790

5.  Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis.

Authors:  Sean Marrache; Shanta Dhar
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

6.  Isolation of Plasma Lipoproteins as a Source of Extracellular RNA.

Authors:  Kang Li; David K Wong; Fu Sang Luk; Roy Y Kim; Robert L Raffai
Journal:  Methods Mol Biol       Date:  2018

7.  Modification of low-density lipoprotein by different radioiodination methods.

Authors:  G Sobal; U Resch; H Sinzinger
Journal:  Nucl Med Biol       Date:  2004-04       Impact factor: 2.408

Review 8.  Aggregation and fusion of low-density lipoproteins in vivo and in vitro.

Authors:  Mengxiao Lu; Olga Gursky
Journal:  Biomol Concepts       Date:  2013-10

9.  Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma.

Authors:  Rui Kuai; Chitra Subramanian; Peter T White; Barbara N Timmermann; James J Moon; Mark S Cohen; Anna Schwendeman
Journal:  Int J Nanomedicine       Date:  2017-09-06

10.  Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression.

Authors:  Yanhong Guo; Wenmin Yuan; Bilian Yu; Rui Kuai; Wenting Hu; Emily E Morin; Minerva T Garcia-Barrio; Jifeng Zhang; James J Moon; Anna Schwendeman; Y Eugene Chen
Journal:  EBioMedicine       Date:  2017-12-20       Impact factor: 8.143
View more
  11 in total

Review 1.  Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles.

Authors:  Sifei Han; Lianghe Mei; Tim Quach; Chris Porter; Natalie Trevaskis
Journal:  Pharm Res       Date:  2021-08-31       Impact factor: 4.200

2.  Extracellular vesicles versus synthetic nanoparticles for drug delivery.

Authors:  Kenneth W Witwer; Joy Wolfram
Journal:  Nat Rev Mater       Date:  2021-01-07       Impact factor: 76.679

3.  Extracellular vesicle therapeutics from plasma and adipose tissue.

Authors:  Dalila Iannotta; Man Yang; Christian Celia; Luisa Di Marzio; Joy Wolfram
Journal:  Nano Today       Date:  2021-04-27       Impact factor: 18.962

4.  Brain metastases-derived extracellular vesicles induce binding and aggregation of low-density lipoprotein.

Authors:  Sara Busatto; Yubo Yang; Sierra A Walker; Irina Davidovich; Wan-Hsin Lin; Laura Lewis-Tuffin; Panagiotis Z Anastasiadis; Jann Sarkaria; Yeshayahu Talmon; Gregory Wurtz; Joy Wolfram
Journal:  J Nanobiotechnology       Date:  2020-11-07       Impact factor: 10.435

5.  A Simple and Quick Method for Loading Proteins in Extracellular Vesicles.

Authors:  Sara Busatto; Dalila Iannotta; Sierra A Walker; Luisa Di Marzio; Joy Wolfram
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-13

6.  Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration delivery for enhanced photo-gene therapy towards glioma.

Authors:  Ruoning Wang; Xiaohong Wang; Junsong Li; Liuqing Di; Jianping Zhou; Yang Ding
Journal:  Bioact Mater       Date:  2021-11-02

Review 7.  The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy.

Authors:  Yongzheng Lu; Xiaolin Cui; Li Zhang; Xu Wang; Yanyan Xu; Zhen Qin; Gangqiong Liu; Qiguang Wang; Kang Tian; Khoon S Lim; Chris J Charles; Jinying Zhang; Junnan Tang
Journal:  Aging Dis       Date:  2022-04-01       Impact factor: 6.745

8.  Considerations for extracellular vesicle and lipoprotein interactions in cell culture assays.

Authors:  Sara Busatto; Yubo Yang; Dalila Iannotta; Irina Davidovich; Yeshayahu Talmon; Joy Wolfram
Journal:  J Extracell Vesicles       Date:  2022-04

Review 9.  Extracellular Vesicles Derived from Mesenchymal Stem Cells: A Potential Biodrug for Acute Respiratory Distress Syndrome Treatment.

Authors:  Hao Sun; Tianyuan Zhang; Jianqing Gao
Journal:  BioDrugs       Date:  2022-09-10       Impact factor: 7.744

10.  Effects of Adipose-Derived Biogenic Nanoparticle-Associated microRNA-451a on Toll-like Receptor 4-Induced Cytokines.

Authors:  Xinghua Wang; Anthony Pham; Lu Kang; Sierra A Walker; Irina Davidovich; Dalila Iannotta; Sarvam P TerKonda; Shane Shapiro; Yeshayahu Talmon; Si Pham; Joy Wolfram
Journal:  Pharmaceutics       Date:  2021-12-22       Impact factor: 6.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.